Valeant avoids double-digit price hikes with 9.9 percent increases
(By Ed Silverman for ST A T) In response to intensifying criticism over drug prices, Allergan chief executive Brent Saunders
Read More(By Ed Silverman for ST A T) In response to intensifying criticism over drug prices, Allergan chief executive Brent Saunders
Read More(By Ed Silverman for ST A T) Y ou can add Colorado to the list of states being sued 1
Read More(By David Armstrong for ST A T) W ELCH, W.Va. — The pharmaceutical sales representatives from health care giant Abbott
Read More(By Helen Branswell for ST A T) C ountries from around the world agreed Wednesday to take concerted efforts to
Read More(By Alison Kodjak for NPR) The drug company that makes the EpiPen says it isn’t nearly as profitable as many
Read More(By Rob Stein for NPR) A scientist in Sweden has started trying to edit the DNA in healthy human embryos,
Read More(By Ayla Ellison and Mackenzie Bean for Becker’s Hospital Review ) Becker’s Hospital Review has named the following organizations to
Read MoreTen thousand seniors turning 65 and becoming Medicare-eligible every day but not one of Silicon Valley companies is taking senior
Read More(By Juiette Cubanski, Tricia Neuman, and Anthony Damico for Kaiser Family Foundation) The latest example of high and rising prescription
Read More(Erin Ross for NPR) Fitness trackers remain wildly popular, but do they make us fit? Maybe not, according to a
Read More